| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/29/2001 | US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/29/2001 | CA2064915C Tumour necrosis factor binding ligands |
| 05/29/2001 | CA2034881C Factor x-laci hybrid protein |
| 05/25/2001 | WO2001036639A2 Bt toxin receptors from lepidopteran insects and methods of use |
| 05/25/2001 | WO2001036489A2 Erythropoietin forms with improved properties |
| 05/25/2001 | WO2001036487A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | WO2001036484A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | WO2001036467A2 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | WO2001036453A2 Ny-eso-1 nanopeptide derivatives, and uses thereof |
| 05/25/2001 | WO2001036452A2 Heteroclitic analogs of class i epitodes |
| 05/25/2001 | WO2001036448A2 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2000067793A8 Death domain containing receptor 4 |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392109A1 Mammalian receptor proteins; related reagents and methods |
| 05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | CA2391080A1 Erythropoietin forms with improved properties |
| 05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
| 05/23/2001 | EP1100969A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 05/23/2001 | EP1100928A2 Enzymes for biopolymer production |
| 05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100899A2 Delta-related polypeptides |
| 05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 05/23/2001 | EP1100830A2 Heterominibodies |
| 05/23/2001 | EP1100815A1 Protease susceptibility ii |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/22/2001 | US6235469 Generation of transcriptional sequences associated with phage envelope protein; incubate and insert nucleotide sequences into expression vector, express gene coded in vector and recover polypeptides |
| 05/22/2001 | CA1341235C Modular assembly of antibody genes, antibodies prepared thereby and use |
| 05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
| 05/17/2001 | WO2001034829A2 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | DE19952956A1 Verfahren zur Verbindung von molekularen Substanzen A method for connection of molecular substances |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2389841A1 Novel nucleic acid molecules encoding cyclised amino acid sequences |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098910A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 05/16/2001 | EP1098664A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 05/16/2001 | CN1295616A Tumor-associated antigen derivatives from MAGE family, and nucleic acid sequence encoding them |
| 05/15/2001 | US6232447 Antibody immunoreactive with a human cytokine designated LERK-6 |
| 05/15/2001 | US6232445 Soluble MHC complexes and methods of use thereof |
| 05/15/2001 | US6232094 DNA encoding human κ casein and process for obtaining the protein |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032893A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032714A1 Recombinant fusion molecules |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032684A2 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389339A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | CA2388955A1 Recombinant fusion molecules |
| 05/10/2001 | CA2388308A1 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097227A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 05/09/2001 | EP1097165A1 Novel inhibitors of angiogenesis and tumor growth |
| 05/09/2001 | EP1096945A1 Lysine binding fragments of angiostatin |
| 05/09/2001 | EP0514411B1 Polypeptides and dna encoding same, associated with human malaria parasites |
| 05/09/2001 | CN1294632A Compsns. derived from i(mycobacterium vaccae) and methods for their use |
| 05/08/2001 | US6228987 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 05/08/2001 | US6228610 Human metabotropic glutamate receptor subtypes (hmR4, hmR6, hmR7) and related DNA compounds |
| 05/08/2001 | US6228372 Polypeptides with amino acid sequences and peptides |
| 05/08/2001 | CA2096010C Recombinant feline coronavirus s proteins |
| 05/03/2001 | WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | WO2001030812A2 Activation of hcv-specific t cells |
| 05/03/2001 | WO2001030811A2 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
| 05/03/2001 | WO2001030371A2 Novel chimeric analgesic peptides |
| 05/03/2001 | WO2000075332A3 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS |
| 05/03/2001 | CA2390084A1 Novel chimeric analgesic peptides |
| 05/03/2001 | CA2388535A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | CA2387897A1 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 05/03/2001 | CA2387680A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/02/2001 | EP1096014A2 Catalytic domain of the human effector cell cycle checkpoint protein kinase, Chk1, materials and methods for identification of inhibitors thereof |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095147A2 Polyketides, their preparation, and materials for use therein |
| 05/02/2001 | EP1095134A1 Method to prepare c-terminal modified peptides |
| 05/02/2001 | EP1094836A2 Methods of raising animals for meat production |
| 05/02/2001 | CN1293207A Fusion protein with improved combining activity to target cell receptor |
| 05/02/2001 | CN1293205A Target-specific cytotoxin chimeric with short-peptide harmone |
| 05/02/2001 | CN1293202A Chimeric toxin including modified targeting part |
| 05/01/2001 | US6225455 Constructs for producing phosphorylated fusion proteins |